prostatic in English

adjective

[prɑ'stætɪk /prɒ-]

pertaining to the prostate gland

Use "prostatic" in a sentence

1. Benign Prostatic Hyperplasia: PSA Test

2. 9 This proved to be prostatic adenocarcinoma.

3. Benign prostatic hyperplasia (BPH), also known as Benign prostatic hypertrophy, is a progressive, non-cancerous enlargement of the prostate

4. Giant multilocular prostatic cystadenoma presenting with obstructive Aspermia

5. Benign prostatic hyperplasia (BPH), also known as Benign prostatic hypertrophy, is a histologic diagnosis characterized by proliferation of the cellular elements of the prostate

6. What are prostatic Concretions? The medical-dictionary defines Prostatic Concretions or Calculus an abnormal concretion, usually composed of mineral salts, occurring within the body, chiefly in hollow organs or their passages.

7. Benightment-- Benign --benign neglect benign prostatic hyperplasia benign prostatic hyperplasia (BPH) benign tumor benign tumour Benignancy Benignant benignantly Benignity Benignly Benim Benin Benin franc Beninese Benison Benitier

8. Zinc Aspartate provides important protection against free radicals, tissue repair and benign prostatic hyperplasia

9. 1 Although Benign prostatic hyperplasia rarely causes symptoms before age 40,

10. Why is Leuprolide acetate bad for prostatic cancer? Transient increase of Androgens in the beginning.

11. Benign prostatic hypertrophy is relatively common and potentially bothersome to aging men.

12. Benign prostatic hyperplasia is the most common prostate problem for men older than age 50

13. We evaluated the association of inflammation, benign prostatic hyperplasia and cancer in Autopsied prostates.

14. 5-alpha reductase inhibiting fermented camellia japonica seed oil for alleviating benign prostatic hypertrophy and baldness

15. In a #-month carcinogenicity study in mice, there was an increased incidence of testicular interstitial cell tumours and prostatic adenomas and adenocarcinomas in males given # or # mg/kg, and prostatic leiomyoblastoma in males given # mg/kg

16. Prostatic carcinoma is known to be androgen sensitive and responds to treatment that removes the source of androgen

17. 2 Objective To explore the regional distribution characteristic of morphosis and cellular proliferation in benign prostatic hyperplasia.

18. The suspicion of prostatic carcinoma could be confirmed in 87.2% by the diagnosis of adenocarcinoma.

19. 23 Not only apoptosis also atrophy and necrosis could be observed in prostatic tissue after castration.

20. Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate gland

21. 21 Objective: To investigate the characteristics of diagnosis and treatment of iatrogenic ejaculatory duct obstruction following prostatic hyperthermia.

22. The absorption of large volumes of irrigation fluid is a major problem in transurethral prostatic surgery (TUR-P).

23. 25 Sacks etal highlighted the importance of prostatic disease as a preventable and treatable cause of renal failure.

24. ⁕Benign tumor ⁕Benign intracranial hypertension ⁕Benign myalgic encephalomyelitis ⁕Benign paroxysmal positional vertigo ⁕Benign prostatic hyperplasia ⁕Benign tertian malaria How to pronounce Benignity?

25. Objective To evaluate the use of two - channel - single - balloon prostatic irrigation catheter in the treatment of chronic prostatitis.

26. 13 Methods: Retrospective analyses were made of the clinical data of 3 cases of ejaculatory duct obstruction following prostatic hyperthermia.

27. In 2010, as many as 14 million men in the United States had lower urinary tract symptoms suggestive of Benign prostatic hyperplasia

28. The PSA test can also be abnormal with Benign enlargement (Benign prostatic hyperplasia or BPH), inflammation (prostatis), and infection of the prostate gland.

29. Adenoma of the prostate gland or prostate Adenoma is an outdated term, the disease is currently classified as benign prostatic hyperplasia (BPH)

30. An aneuploid pattern of prostatic cancer defined by flow cytometry was shown to be of value in predicting progression rates and patient survival times.

31. 26 OBJECTIVE To explore action mechanism of total flavonoids from Bastard Speedwell (TFBS) on prostatic hyperplasia rats model induced by castration and testosterone propionate.

32. The corresponding concentrations in the prostatic adenoma tissue were 8.8 μg/g, 15.3 μg/g, 22.9 μg/g, 4.3 μg/g and 2.7 μg/g respectively.

33. Alate Health provides the safest & most effective treatment options available to men with enlarged prostate symptoms— including treating benign prostatic hypertrophy with prostate artery embolization.

34. Objective To study the inhibition of vibramycin on the expression of matrix metalloproteinase 2 (MMP and the invasiveness of androgen independent prostatic carcinoma cell line PC 3 in vitro.

35. The seed, leaf, and root are used to make medicine. Annatto is used for enlarged prostate (benign prostatic hyperplasia or BPH), diabetes, stomach problems, skin problems, and

36. It is also shown that 81% at least can be decreased in blood supply of the prostate gland as the prostatic arterial trunk and the accessory pudendal artery are ligated.

37. A group of scientists examined some of this ejaculatory fluid and discovered prostatic enzymes, fuelling the theory that the G-spot is the equivalent of the male prostate.

38. More particularly, the said nicotinamide derivatives have anti-androgen activity, so that they can be effectively used as a preventive or therapeutic agent for androgen-related diseases such as prostatic disease, androgenic alopecia and acne.

39. Women are more prone to UTIs than men because in females , the urethra is much shorter and closer to the anus than in males , and they lack the bacteriostatic properties of prostatic secretions .

40. The present invention relates to substituted isoindole-1,3-dione compounds of Formula (I) and pharmaceutically acceptable forms thereof, as &agr;1a/&agr;1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms.

41. We conclude that due to modern 3D-planned conformal techniques with optimization of treatment dose and improved protection of critical organs such as urinary bladder and rectum, radiotherapy, allows an effective and well tolerated therapy of localized prostatic carcinoma.

42. The present invention relates to a new pharmaceutical combination for treating benign prostatic hyperplasia (BPH) or for treating abacterial prostatitis, containing a combination of the active substances tamsulosin or an acid addition salt thereof and a non-steroidal anti-inflammatory drug.

43. With the Abundancy of VDRs in prostatic epithelial and stromal cells, it has also been shown that there is increased apoptosis of periprostatic adipose tissue in VDR knock-out mice (54) indicating a possible role of VDR in the signaling pathways of prostate cancer inhibition

44. ‘Thyrotoxicosis, Anticholinergic drug poisoning, and amphetamine or cocaine use can result in signs of increased sympathetic activity and altered mental status.’ ‘Older men with prostatic hypertrophy may benefit from alpha-blocker medications and should be watched for urinary retention if Anticholinergic drugs are employed.’

45. The present invention relates to an N-Phenyl-2-pyrimidine-aminine derivative showing a superior effect on lung cancer, gastric cancer, colon cancer, pancreatic cancer, hepatoma, prostatic cancer, breast cancer, chronic or accute leukemia, hematologic malignancy, encephalophyma, bladder cancer, rectal cancer or cervical cancer, etc. of warm blooded animals and its salt.

46. The phenyltriazole derivatives of the present invention have an excellent activity as GABAb agonist and are useful for the prophylaxis and treatment of diseases associated with GABAb activity, in particular for the treatment of overactive bladder, urinary incontinence such as urge urinary incontinence, benign prostatic hyperplasia (BPH), chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, or nerve injury.

47. Such compounds are expected to be useful in treatment of human diseases, including, but not limited to: infections such as bacterial, fungal, protozoan and viral infections, particularly infections caused by HIV-1 or HIV-2; pain; cancers; diabetes, obesity; anorexia; bulimia; asthma; Parkinson's disease; acute heart failure; hypotension; hypertension; urinary retention; osteoporosis; angina pectoris; myocardial infarction; stroke; ulcers, asthma; allergies; benign prostatic hypertrophy; migraine; vomiting; psychotic and neurological disorders, including anxiety, schizophrenia, manic depression, depression, dementia, and severe mental retardation; and dyskinesias, such as Huntington's disease or Gilles de la Tourett's syndrome.